I will disagree with you about this. Some explanation and reassurance by our chairman at this time would calm investor fears about the timing of trials, the reasons for the various delays that inevitably happen, and the future direction of the company. Heck I wouldn't mind them paying for some publicity regarding our latest milestone. I would be sounding the trumpets about it if I could. No one in the industry has done such a thing with a cannabis based medicine except GW, and look at their pps.